Skip to main content
SpringerLink
Log in

Nasal Polyposis: Current Trends

  • Review Article
  • Published:
Indian Journal of Otolaryngology and Head & Neck Surgery Aims and scope Submit manuscript

Abstract

Nasal polyps (NP) are one of the most common inflammatory mass lesions of the nose, affecting up to 4% of the population. They present with nasal obstruction, anosmia, rhinorrhoea, post nasal drip, and less commonly facial pain. Their etiology remains unclear, but they are known to have associations with allergy, asthma, infection, fungus, cystic fibrosis, and aspirin sensitivity. However, the underlying mechanisms interlinking these pathologic conditions to NP formation remain unclear. Also strong genetic factors are implicated in the pathogenesis of NP, but genetic and molecular alterations required for its development and progression are still unclear. Management of NP involves a combination of medical therapy and surgery. There is good evidence for the use of corticosteroids (systemic and topical) both as primary treatment and as postoperative prophylaxis against recurrence, but the prolonged course of the disease and adverse effects of systemic steroids limits their use. Hence several new drugs are under trial. Surgical treatment has been refined significantly over the past 20 years with the advent of endoscopic sinus surgery and, in general, is reserved for cases refractory to medical treatment. Recurrence of the polyposis is common with severe disease recurring in up to 10% of patients. Over the last two decades, increasing insights in the pathophysiology of nasal polyposis opens perspective for new pharmacological treatment options, with eosinophilic inflammation, IgE, fungi and Staphylococcus aureus as potential targets. A better understanding of the pathophysiology underlying the persistent inflammatory state in NP is necessary to ultimately develop novel pharmacotherapeutic approaches. In this paper we present the newer treatment options available for better control and possibly cure of the disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Fajardo-Dolci G, Solorio-Abreu J, Romero-Alvarez JC, Zavaleta-Villa B, Cerezo-Camacho O, Jimenez-Lucio R et al (2006) DQA1 and DQB1 association and nasal polyposis. Otolaryngol Head Neck Surg 135(2):243–247

    Article  PubMed  Google Scholar 

  2. Liu Z, Kim J, Sypek JP, Wang IM, Horton H, Oppenheim FG et al (2004) Gene expression profiles in human nasal polyp tissues studied by means of DNA microarray. J Allergy Clin Immunol 114(4):783–790

    Article  CAS  PubMed  Google Scholar 

  3. Ramanathan M Jr, Lee WK, Spannhake EW, Lane AP (2008) Th2 cytokines associated with chronic rhinosinusitis with polyps down-regulate the antimicrobial immune function of human sinonasal epithelial cells. Am J Rhinol 22(2):115–121

    Article  PubMed Central  PubMed  Google Scholar 

  4. Kim TH, Lee HM, Lee SH, Kim HK, Lee JH, Oh KH (2008) Down-regulation of carbonic anhydrase isoenzymes in nasal polyps. Laryngoscope 118(10):1856–1861

    Article  CAS  PubMed  Google Scholar 

  5. Davis LJ, Kita H (2004) Pathogenesis of chronic rhinosinusitis: role of airborne fungi and bacteria. Immunol Allergy Clin North Am 24:59–73

    Article  PubMed  Google Scholar 

  6. Inoue Y, Matsuwaki Y, Shin SH et al (2005) Nonpathogenic, environmental fungi induce activation and degranulation of human eosinophils. J Immunol 175:5439–5447

    CAS  PubMed  Google Scholar 

  7. Weschta M, Rimek D, Formanek M, Polzehl D, Riechelmann H (2003) Local production of Aspergillus fumigatus specific immunoglobulin E in nasal polyps. Laryngoscope 113:1798–1802

    Article  CAS  PubMed  Google Scholar 

  8. Gilbert P, Maira-Litran T, McBain AJ, Rickard AH, Whyte FW (2002) The physiology and collective recalcitrance of microbial biofilm communities. Adv Microb Physiol 46:202–256

    PubMed  Google Scholar 

  9. Foreman A, Psaltis AJ, Tan LW, Wormald PJ (2009) Characterization of bacterial and fungal biofilms in chronic rhino-sinusitis. Am J Rhinol Allergy 23(6):556–561

    PubMed  Google Scholar 

  10. Kilty SJ, Desrosiers MY (2008) The role of bacterial biofilms and the pathophysiology of chronic rhinosinusitis. Curr Allergy Asthma Rep 8(3):227–233

    Article  CAS  PubMed  Google Scholar 

  11. Pujols L, Alobid I, Benitez P, Martinez-Antón A, Roca-Ferrer J, Fokkens WJ, Mullol J, Picado C (2008) Regulation of glucocorticoid receptor in nasal polyps by systemic and intranasal glucocorticoids. Allergy 63:1377–1386

    Article  CAS  PubMed  Google Scholar 

  12. Grzanka A, Misiołek M, Golusiński W, Jarząb J (2011) Molecular mechanisms of glucocorticoids action: implications for treatment of rhinosinusitis and nasal polyposis. Eur Arch Otorhinolaryngol 268(2):247–253

    Article  PubMed Central  PubMed  Google Scholar 

  13. Modrzynski M, Zavisza E, Rapiejko P (2002) Zafirlukast in treatment of nasal polyposis in patients with aspirin intolerant bronchial asthma-preliminary report. Pol Merkur Lekarski 12(69):224–227

    PubMed  Google Scholar 

  14. Zhang N, Gevaert P, Van Zele T, Perez-Novo C, Patou J, Holtappels G, Van Cauwenberge P, Bachert C (2005) An update on the impact of Staphylococcus aureus enterotoxins in chronic sinusitis with nasal polyposis. Rhinology 43:162–168

    CAS  PubMed  Google Scholar 

  15. Kutting B, Nieschalk M, Brehler K (2000) A new concept for treatment of sinonasal polyposis. Allergy 55:1091–1092

    Article  CAS  PubMed  Google Scholar 

  16. Zhang N, Gevaert P, van Zele T, Perez-Novo C, Patou J, Holtappels G, van Cauwenberge P, Bachert C (2005) An update on the impact of Staphylococcus aureus enterotoxins in chronic sinusitis with nasal polyposis. Rhinology 43(3):162–168

    CAS  PubMed  Google Scholar 

  17. Van Zele T, Gevaert P, Holtappels G, Beule A, Wormald PJ, Mayr S, Hens G, Hellings P, Ebbens FA, Fokkens W, Van Cauwenberge P, Bachert C (2010) Oral steroids and doxycycline: two different approaches to treat nasal polyps. J Allergy Clin Immunol 125(5):1069–1076

    Article  PubMed  Google Scholar 

  18. Incorvaia C, Mauro M, Riario-Sforza GG, Frati F, Tarantini F, Caserini M (2008) Current and future applications of the anti-IgE antibody omalizumab. Biologics 2(1):67–73

    CAS  PubMed Central  PubMed  Google Scholar 

  19. Holgate ST, Djukanovid R, Casale T, Bousquet J (2005) Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy. Clin Exp Allergy 35(4):408–416

    Article  CAS  PubMed  Google Scholar 

  20. Pletcher SD, Goldberg AN (2010) Treatment of recurrent sinonasal polyposis with steroid-infused carboxymethylcellulose foam. Am J Rhinol Allergy 24(6):451–453

    Article  PubMed  Google Scholar 

  21. Duffy SM, Lawley WJ, Kaur D, Yang W, Bradding P (2003) Inhibition of human mast cell proliferation and survival by tamoxifen in association with ion channel modulation. J Allergy Clin Immunol 112:965–972

    Article  CAS  PubMed  Google Scholar 

  22. Bernstein JM (2001) The molecular biology of nasal polyposis. Curr Allergy Asthma Rep 1:262–267

    Article  CAS  PubMed  Google Scholar 

  23. Passàli D, Bellussi L, Lauriello M, Ferrara A, Bernstein JM (1996) Medical therapy for prevention of relapsing nasal polyposis: a pilot study on the use of furosemide by inhalation. Am J Rhinol 10:187–192

    Article  Google Scholar 

  24. Levasseur-Acker GM, Molimard M, Regnard J, Naline E, Freche C, Lockhart A (1994) Effect of furosemide on prostaglandin synthesis by human nasal and bronchial epithelial cells in culture. Am J Respir Cell Mol Biol 10(4):378–383

    Article  CAS  PubMed  Google Scholar 

  25. Passàli D, Bernstein JM, Passàli FM, Damiani V, Passàli GC, Bellussi L (2003) Treatment of recurrent chronic hyperplastic sinusitis with nasal polyposis. Arch Otolaryngol Head Neck Surg 129:656–659

    Article  PubMed  Google Scholar 

  26. Passàli D, Mezzedimi C, Passàli GC, Bellussi L (2000) Efficacy of inhalation form of furosemide to prevent postsurgical relapses of rhinosinusal polyposis. J Otorhinolaryngol 62:307–310

    Google Scholar 

  27. Shin SH, Ye MK (2004) Effects of topical amphotericin B on expression of cytokines in nasal polyps. Acta Otolaryngol 124(10):1174–1177

    Article  CAS  PubMed  Google Scholar 

  28. Kern BE, Sherris D, Stergiou AM, Katz LM, Rosenblatt LC, Ponikau JU (2007) Diagnosis and treatment of chronic rhinosinusitis: focus on intranasal Amphotericin B. Ther Clin Risk Manag 3(2):319–325

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  29. Groll AH, Gea-Banacloche JC, Glasmacher A et al (2003) Clinical pharmacology of antifungal compounds. Infect Dis Clin North Am 17:159–191

    Article  PubMed  Google Scholar 

  30. Ponikau JU, Sherris DA, Weaver A, Kita H (2005) Treatment of chronic rhinosinusitis with intranasal amphotericin B: a randomized, placebo-controlled, double-blind pilot trial. J Allergy Clin Immunol 15:125–131

    Article  Google Scholar 

  31. Ricchetti A, Landis BN, Giger R, Zheng C, Lacroix JS (2002/2003) Effect of local antifungal treatment on nasal polyposis. Otorhinoloaryngologia 12(2):48–51

    Google Scholar 

  32. Wise GJ, Kozinn PJ, Goldberg P (1982) Amphotericin B as a urologic irrigant in the management of noninvasive candiduria. J Urol 128:82–84

    CAS  PubMed  Google Scholar 

  33. Telmesani LM (2009) Prevalence of allergic fungal sinusitis among patients with nasal polyps. Ann Saudi Med 29(3):212–214

    PubMed  Google Scholar 

  34. Poetker DM, Mendolia-Loffredo S, Smith TL (2007) Outcomes of endoscopic sinus surgery for chronic rhinosinusitis associated with sinonasal polyposis. Am J Rhinol 21:84–88

    Article  PubMed  Google Scholar 

  35. Bhattacharyya N (2007) Influence of polyps on outcomes after endoscopic sinus surgery. Laryngoscope 117:1834–1838

    Article  PubMed  Google Scholar 

  36. Wynn R, Har-El G (2007) Recurrence rates after endoscopic sinus surgery for massive sinus polyposis. Laryngoscope 114:811–813

    Article  Google Scholar 

  37. Anon JB (1998) Computer-aided endoscopic sinus surgery. Laryngoscope 108:949–961

    Article  CAS  PubMed  Google Scholar 

  38. Olson G, Citardi MJ (2000) Image-guided functional endoscopic sinus surgery. Otolaryngol Head Neck Surg 123:188–194

    Article  CAS  PubMed  Google Scholar 

  39. Al-Swiahb JN, Al-Dousary SH (2010) Computer-aided endoscopic sinus surgery: a retrospective comparative study. Ann Saudi Med 30(2):149–152

    Article  PubMed  Google Scholar 

  40. Talbot AR, Herr TM, Parsons DS (1997) Mucocilliary clearance and buffered hypertonic saline solution. Laryngoscope 107:500–503

    Article  CAS  PubMed  Google Scholar 

  41. Newton RJ, Ah-See KW (2008) A review of nasal polyposis. Ther Clin Risk Manag 4(2):507–512

    PubMed Central  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Institute of Aerospace Medicine, Vimanpura, Near Hal Airport, Bangalore, 560017, Karnataka, India

    Renu Rajguru

Authors
  1. Renu Rajguru
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Renu Rajguru.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rajguru, R. Nasal Polyposis: Current Trends. Indian J Otolaryngol Head Neck Surg 66 (Suppl 1), 16–21 (2014). https://doi.org/10.1007/s12070-011-0427-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12070-011-0427-z

Keywords

Search

Navigation